Clinical Trial Update: Characterizing the Use of Ofatumumab in a Real World Setting

View source ↗

Summary

A completed real-world observational study evaluating how ofatumumab is used to treat relapsing multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Kesimpta (ofatumumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Relapsing Multiple Sclerosis | Status: COMPLETED